Issued Patents All Time
Showing 1–25 of 62 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12187731 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2025-01-07 |
| 11370798 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2022-06-28 |
| 11117900 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2021-09-14 |
| 10961232 | Substituted pyrazines as ATR kinase inhibitors | Jean-Damien Charrier, Steven Durrant, Ronald Knegtel, Somhairle MacCormick, Michael Mortimore +6 more | 2021-03-30 |
| 10787452 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2020-09-29 |
| 10479784 | Substituted pyrazin-2-amines as inhibitors of ATR kinase | Jean-Damien Charrier, Steven Durrant, Ronald Knegtel, Somhairle MacCormick, Michael Mortimore +6 more | 2019-11-19 |
| 10392391 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2019-08-27 |
| 9718827 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Christopher John Davis, Rebecca Davis +14 more | 2017-08-01 |
| 9701674 | Substituted pyrazines as ATR kinase inhibitors | Jean-Damien Charrier, Steven Durrant, Ronald Knegtel, Somhairle MacCormick, Michael Mortimore +6 more | 2017-07-11 |
| 9663519 | Compounds useful as inhibitors of ATR kinase | Jean-Damien Charrier, Chris Davis, Steven Durrant, Gorka Etxebarria I Jardi, Damien Fraysse +4 more | 2017-05-30 |
| 9650381 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2017-05-16 |
| 9630956 | Compounds useful as inhibitors of ATR kinase | Jean-Damien Charrier, Hayley Binch, Dennis James Hurley, Thomas Cleveland, Pramod Joshi +10 more | 2017-04-25 |
| 9365557 | Substituted pyrazin-2-amines as inhibitors of ATR kinase | Jean-Damien Charrier, Steven Durrant, Ronald Knegtel, Somhairle MacCormick, Michael Mortimore +6 more | 2016-06-14 |
| 9340546 | Compounds useful as inhibitors of ATR kinase | Nadia Ahmad, Dean Boyall, Jean-Damien Charrier, Chris Davis, Rebecca Davis +14 more | 2016-05-17 |
| 8969360 | Compounds useful as inhibitors of ATR kinase | Jean-Damien Charrier, Chris Davis, Steven Durrant, Damien Fraysse, Juan-Miguel Jimenez +6 more | 2015-03-03 |
| 8957078 | Compounds useful as inhibitors of ATR kinase | Guy Brenchley, Jean-Damien Charrier, Chris Davis, Steven Durrant, Gorka Etxebarria I Jardi +9 more | 2015-02-17 |
| 8877759 | Aminopyrazines as ATR kinase inhibitors | Jean-Damien Charrier, Somhairle MacCormick, Pierre-Henri Storck, Joanne Pinder, Michael O'Donnell +6 more | 2014-11-04 |
| 8846918 | Compounds useful as inhibitors of ATR kinase | Jean-Damien Charrier | 2014-09-30 |
| 8841308 | Pyrazin-2-amines useful as inhibitors of ATR kinase | Jean-Damien Charrier, Ronald Knegtel, Somhairle MacCormick, Michael O'Donnell, Joanne Pinder +1 more | 2014-09-23 |
| 8779127 | Processes for preparing substituted pyrimidines | Jean-Damien Charrier, Francesca Mazzei, Andrew Miller | 2014-07-15 |
| 8759389 | Thiophene-carboxamides useful as inhibitors of protein kinases | Guy Brenchley, Jean-Damien Charrier, Steven Durrant, Ronald Knegtel, Sharn Ramaya +1 more | 2014-06-24 |
| 8669081 | Compositions useful as inhibitors of protein kinases | David Bebbington, Hayley Binch, Jean-Damien Charrier, Simon Everitt, Julian Golec +3 more | 2014-03-11 |
| 8637666 | Methods for preparing pyrimidine derivatives useful as protein kinase inhibitors | Jean-Damien Charrier, Steven Durrant | 2014-01-28 |
| 8557818 | Compounds useful as protein kinase inhibitors | Jean-Damien Charrier, Ronald Knegtel | 2013-10-15 |
| 8524902 | [1,2,4]triazolo[4,3-f]pteridines useful as inhibitors of protein kinases | Jean-Damien Charrier, Ronald Knegtel | 2013-09-03 |